A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212

Clinical trial NCT07093697 · COMPLETED

Trial details

NCT number: NCT07093697
Sponsor: Daewon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Bronchitis

Start date: 2024-03-28
Primary completion: 2025-05-27
Enrollment: 273

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.